DZ Bank
PDLI

DZ Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

DZ Bank’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-861,151
Closed -$2.02M – 891
2018
Q2 		$2.02M Hold
861,151
– – 0.01% 496
2018
Q1 		$2.53M Hold
861,151
– – 0.01% 514
2017
Q4 		$2.36M Hold
861,151
– – 0.01% 470
2017
Q3 		$2.92M Buy
861,151
+308,045
+56% +$857K 0.01% 444
2017
Q2 		$1.37M Sell
553,106
-556,021
-50% -$1.28M 0.01% 520
2017
Q1 		$2.52M Sell
1,109,127
-108,891
-9% -$241K 0.01% 457
2016
Q4 		$2.58M Buy
+1,218,018
New +$3.4M 0.01% 432

Other funds holding PDLI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

DZ Bank's PDLI Position: Q3 2018 in Review

DZ Bank sold out of PDL BioPharma, Inc. (PDLI) in Q3 2018, closing a stake of 861,151 shares — an estimated $2.02M sold.

DZ Bank first reported a position in PDLI in Q4 2016 and held it in 7 quarters. The position peaked at $2.92M in Q3 2017. 152 funds tracked by Wall St. Rank hold PDLI as of Q3 2018.

  • DZ Bank reported no remaining PDL BioPharma, Inc. position as of Q3 2018 after selling out during the quarter.
  • DZ Bank sold 861,151 PDL BioPharma, Inc. shares in Q3 2018, an estimated $2.02M.
  • DZ Bank first reported a position in PDL BioPharma, Inc. in Q4 2016 and held it in 7 quarters.
  • DZ Bank's PDL BioPharma, Inc. position peaked at $2.92M in Q3 2017.
  • 152 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2018.

Based on DZ Bank's 13F filing for Q3 2018, filed 14 Nov 2018.